Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc. (LSTA) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
lsta · stock forecast · 2 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 2 Wall Street analysts in the past 3 months
Hold
2 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $3.48
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $3.61 | ↑ 3.80% |
1-day model range: $3.58–$3.64. Peak: $3.64 (+3.80%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · LSTA · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-15 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2026-01-21 | Brookline Capital | Downgrade ↓ | Buy→Hold |
| 2025-08-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-07-15 | Brookline Capital | Maintains | Buy→Buy |
| 2024-12-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-09-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-07-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-07-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Lisata Therapeutics, Inc. (LSTA) stock. Of the recent 20 rating actions, 0 were upgrades and 2 were downgrades. 2 analysts currently cover LSTA.
Analyst Recommendation Trends
LSTA analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 99.3% YoY
Revenue Next Year
$0M
↑ 304.2% YoY
EPS This Year
$-2.33
EPS Next Year
$-1.09
↓ 53.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast LSTA EPS of $-2.33 for the current fiscal year, based on estimates from 1 analysts. The LSTA revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The LSTA stock forecast is supported by two independent data sources: analyst consensus ratings from 2 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus LSTA price target is $0.00 (+0.0% upside), with an analyst consensus of Hold.
The LSTA short-term stock prediction for tomorrow is $3.61 (+3.80%).
Lisata Therapeutics, Inc. trades on NASDAQ under the ticker LSTA. The LSTA stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 0% of covering analysts.
Frequently asked questions
LSTA forecast · 8 questionsAccording to 2 Wall Street analysts, the average 12-month LSTA price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $3.48.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.